Palisade Bio, Inc. Profile Avatar - Palmy Investing

Palisade Bio, Inc.

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract…

Biotechnology
US, Carlsbad [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of PALI's Analysis
CIK: 1357459 CUSIP: 696389105 ISIN: US6963892046 LEI: - UEI: -
Secondary Listings
PALI has no secondary listings inside our databases.